Multiple sclerosis is especially destructive because of its tendency to worsen progressively. Instead of working through the immune system, Quantum BioPharma’s Lucid-MS acts directly on the myelin ...
A registry study led by the University of Oulu examined the early-stage treatment of relapsing-remitting multiple sclerosis (MS) in Finland between 2013 and 2022. According to the study published in ...
This article has been disseminated on behalf of Quantum BioPharma Ltd. and may include paid advertising. Quantum ...
Researchers have identified six key proteins that could be targeted to combat MS progression, and potential drugs that could ...
PARIS — The first real guidelines on the use of disease-modifying therapies in multiple sclerosis (MS) have been released by a European joint venture between the European Committee for Research and ...
MS is a chronic, immune-mediated disease affecting the central nervous system, with no known cure and varying levels of impact on individuals. Over 20 FDA-approved disease-modifying therapies exist, ...
Treatment with interferon or with glatiramer acetate? This question arises for many patients who receive a diagnosis of multiple sclerosis (MS) for the first time. Until now, the choice between the ...
HOUSTON & WALTHAM, Mass.--(BUSINESS WIRE)--Biostate AI, a leading innovator in artificial intelligence for RNA sequencing, today announced a strategic partnership with the Accelerated Cure Project ...
Denver7 KMGH Denver, CO on MSN
Multiple sclerosis in Colorado: Efforts to improve treatment
1 in 173 Coloradans have multiple sclerosis in Colorado. Denver7's Danielle Kreutter reports on the efforts for better ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results